• Hub71 partnered with Unilabs to speed development, testing, validation, and commercial adoption of new health technologies in Abu Dhabi.
• Unilabs joined Hub71+ Life Sciences as an anchor market partner, giving startups access to diagnostics, imaging, clinical expertise, and its healthcare network.
• Collaboration pipeline includes technology integrations, proofs of concept, and commercial partnerships to turn startup products into customer-facing healthcare services.
• Initial projects cover Takalam’s digital mental health platform and GlycanAge’s biological-age testing, expanding Unilabs into mental health services.
• Hub71+ Life Sciences launched in 2025 with DoH, EDE, and the HELM cluster; Unilabs’ entry strengthens market access routes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hub71 Ltd published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.